The discrepancy in the range of temperatures at which MCU and NCLX are inhibited, (37–25 °C) and (37–15 °C), respectively, would have strong consequences on the net flux of Ca2+ and could participate in the increase in CRC value. The gene discussed is SLC8B1; the disease is colorectal carcinoma.